Stocks · Health care · Pharmaceutical Preparations

Korro Bio, Inc.

KRRO Clue Score32
United States Fiscal year ends December CIK 0001703647 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ram Aiyar
4 Aug 2026
President and CEO
Sell
5,802
$10.84
$62.92K
Oliver Dolan
16 Jun 2026
Senior Vice President, Finance
Sell
3,383
$10.83
$36.64K
Jeffrey Cerio
16 Jun 2026
General Counsel
Sell
6,609
$10.83
$71.58K
Loic A Vincent
16 Jun 2026
Chief Scientific Officer
Sell
3,418
$10.83
$37.02K
Todd Chappell
16 Jun 2026
Chief Operating Officer
Sell
3,168
$10.83
$34.31K
Ram Aiyar
29 May 2026
President and CEO
Sell
15,152
$12.98
$196.67K

What was left out

Form 4 filings counted 48
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 0
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 429,331
History held since 2 Oct 2019